---
title: "Repligen soars 16% after blockbuster earnings, FY25 guidance upgrade"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294103076.md"
description: "Repligen (RGEN) shares surged up to 16% following strong second-quarter earnings and an upgraded full-year guidance. The company reported adjusted EPS of $0.54, beating estimates by $0.09, with revenue reaching $204.1 million."
datetime: "2026-07-28T19:02:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294103076.md)
  - [en](https://longbridge.com/en/news/294103076.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294103076.md)
generator: "portal-rs"
---

# Repligen soars 16% after blockbuster earnings, FY25 guidance upgrade

Repligen (RGEN) shares rose as much as 16% during Tuesday’s trading following blockbuster second-quarter results and an upward revision to its full-year guidance. RGEN shares advanced 15.91% to $151.91 during midday trading. The company posted adjusted per-share earnings of $0.54, beating estimates by $0.09, while it reported revenue of $204.1M, be...

### Related Stocks

- [RGEN.US](https://longbridge.com/en/quote/RGEN.US.md)

## Related News & Research

- [Repligen Corporation $RGEN Shares Sold by Baird Financial Group Inc.](https://longbridge.com/en/news/298799472.md)
- [Repligen announces long-serving director Karen Dawes’ retirement](https://longbridge.com/en/news/299094707.md)
- [Repligen CEO Olivier Loeillot disposes of USD 985,896.05 in common shares](https://longbridge.com/en/news/298360540.md)
- [BioLife Solutions Nears Completion of Repligen Acquisition](https://longbridge.com/en/news/298517751.md)
- [BioLife Solutions announces special shareholder meeting on merger agreement](https://longbridge.com/en/news/298506483.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**